Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Published Erratum
. 2016 Sep;17(5):669-670.
doi: 10.5811/westjem.2016.8.32230. Epub 2016 Aug 23.

Erratum: This Article Corrects: "Anticoagulation Reversal and Treatment Strategies in Major Bleeding: Update 2016"

Steve Christos  1 , Robin Naples  2
Affiliations
Published Erratum

Erratum: This Article Corrects: "Anticoagulation Reversal and Treatment Strategies in Major Bleeding: Update 2016"

Steve Christos et al. West J Emerg Med. 2016 Sep.

Abstract

[This corrects the article on p. 264 in vol. 17, PMID: 27330657.].

PubMed Disclaimer

Figures

Figure 3
Figure 3
Reversal of direct oral anticoagulants (DOACs) in patients with significant bleeding. IV, intravenous; FFP, fresh frozen plasma; rFVIIa, Recombinant human Factor VIIa; PCC, prothrombin complex concentrates; FEIBA, Factor Eight Inhibitor Bypassing Activity; NG, nasogastric #Off label use. ^4F-PCC contains heparin and is contraindicated in patients with a history of heparin induced thrombocytopenia. ¥Not currently available on market. FDA trials ongoing. Dosing based on published Phase 3 trial.
Figure 3
Figure 3
Reversal of direct oral anticoagulants (DOACs) in patients with significant bleeding. IV, intravenous; FFP, fresh frozen plasma; rFVIIa, Recombinant human Factor VIIa; PCC, prothrombin complex concentrates; FEIBA, Factor Eight Inhibitor Bypassing Activity; NG, nasogastric #Off label use. ^4F-PCC contains heparin and is contraindicated in patients with a history of heparin induced thrombocytopenia. ¥Not currently available on market. FDA trials ongoing. Dosing based on published Phase 3 trial.
See this image and copyright information in PMC

Erratum for

Publication types